Search

Your search keyword '"Stefanović, Aleksandra"' showing total 444 results

Search Constraints

Start Over You searched for: Author "Stefanović, Aleksandra" Remove constraint Author: "Stefanović, Aleksandra"
444 results on '"Stefanović, Aleksandra"'

Search Results

201. Oxidative stress biomarker monitoring in elite women volleyball athletes during a 6-week training period

203. Oxidative Stress and Anti-oxidative Defense in Schoolchildren Residing in a Petrochemical Industry Environment

204. Beneficial effects of dimethyl sulfoxide on tungstates hepatoprotecitve activity

205. Long-term Effects of Oxidative Stress in Volleyball Players

206. Oxidative stress, HDL and atherosclerosis

207. Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats

208. Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease

209. Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population

210. Diagnostic value of CSF proteins assay in differential diagnosis of CNS disease

212. Dyslipidemia and oxidative stress in sarcoidosis patients

217. Preliminary experience with 18f-fluoro-deoxy-glucose positron emission tomography/computed tomography in pediatric oncology patients.

218. Association of oxidative stress and paraoxonase status with PROCAM risk score

219. The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients

220. Non-Coding RNAs in Preeclampsia—Molecular Mechanisms and Diagnostic Potential.

222. Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease.

223. BIM to BREEAM: A workflow for automated daylighting assessment of existing buildings.

224. PEDIATRIC NEPHROTIC SYNDROME: THE INTERPLAY OF OXIDATIVE STRESS AND INFLAMMATION.

225. Paraoxonase 1 and atherosclerosis‐related diseases.

226. Cholesterol Metabolic Profiling of HDL in Women with Late-Onset Preeclampsia.

227. METODOLOGIJA ULTRASONOGRAFSKOG MERENJA VISCERALNOG I SUPKUTANOG ABDOMINALNOG MASNOG TKIVA KOD GOJAZNIH.

228. Altered high-density lipoprotein particle structure and antioxidant capacity in preeclampsia.

229. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.

230. Lipoproteins and cholesterol homeostasis in paediatric nephrotic syndrome patients.

231. Effects of Apnea, Obesity, and Statin Therapy on Proprotein Convertase Subtilisin/Kexin 9 Levels in Patients with Obstructive Sleep Apnea.

232. Antioxidant status in hypertensive disorders of pregnancy.

234. Use of FMF algorithm for prediction of preeclampsia in high risk pregnancies: a single center longitudinal study.

235. Transforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 Diabetes Mellitus.

236. The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.

237. Allele frequencies and forensic parameters of 22 autosomal STR loci in a population of 983 individuals from Serbia and comparison with 24 other populations.

238. Antioxidant status and clinicopathologic parameters in patients with Parkinson's disease.

239. Oxidative stress status in women with high-risk pregnancies with and without complications

240. Значај одређивања маркера инфламације у процени ризика за развој прееклампсије

241. Remodeling of high-density lipoproteins in high-risk pregnancies

242. Ispitivanje prediktivnog i dijagnostičkog značaja pojedinačnih i kombinovanih biomarkera lipidnog statusa i inflamacije kod pacijenata sa kolorektalnim karcinomom

243. Маркери инфламације и оксидативног стреса код педијатријских пацијената са нефротским синдромом

244. Маркери синтезе и апсорпције холестерола у нефротском синдрому

245. Дисфункционалност липопротеинских честица високе густине у високоризичној трудноћи

246. Analysis of plasma lipid composition and lipid peroxidation parameters according to stage and duration of Parkinsonʼs disease and applied therapy disease and applied therapy

247. L-FABP can be an early marker of acute kidney injury in children.

248. Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease.

249. Antioxidant status in hypertensive disorders of pregnancy.

250. Značaj određivanja mijeloperoksidaze i raspodele subfrakcija lipoproteinskih čestica niske i visoke gustine kod dece i adolescenata sa hroničnim bolestima bubrega

Catalog

Books, media, physical & digital resources